Understanding the diverse functions of Huatan Tongluo Fang on rheumatoid arthritis from a pharmacological perspective

Zheng,Chunsong; Qiu,Mingshan; Xu,Xiaojie; Ye,Hongzhi; Zhang,Qian; Li,Yihan; Liu,Xianxiang; Chen,Jinchun

doi:10.3892/etm.2016.3329

Understanding the diverse functions of Huatan Tongluo Fang on rheumatoid arthritis from a pharmacological perspective

Authors:
- Chunsong Zheng
- Mingshan Qiu
- Xiaojie Xu
- Hongzhi Ye
- Qian Zhang
- Yihan Li
- Xianxiang Liu
- Jinchun Chen
View Affiliations

Affiliations: Institute of Bone Disease, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China, Department of Rheumatism and Immunology, Affiliated Xiamen Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Xiamen, Fujian 361009, P.R. China
Published online on: May 11, 2016 https://doi.org/10.3892/etm.2016.3329
Pages: 87-94
Copyright: © Zheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Huatan Tongluo Fang (HTTLF) is a traditional herbal formula that can resolve phlegm and dredge collaterals. HTTLF has also been used to treat rheumatoid arthritis (RA); however, the mechanism underlying the therapeutic effects of HTTLF on RA has not been clearly elucidated at the molecular level. In the present study, an integrated model of system pharmacology containing chemical space analysis, potential active compound prediction and compound-target-disease network was constructed to investigate the molecular mechanisms of HTTLF. The compounds from HTTLF dispersed well in the chemical space. Most of the compounds from HTTLF had similar chemical spaces to drug/drug‑like compounds associated with RA, according to the MDL Drug Data Report. A total of 127 potentially active compounds and 17 targets of RA were identified. Among them, 50 compounds interacted with ≥2 targets, while 77 compounds interacted with only one target. In addition, 17 targets were associated with 82 diseases that belonged to 26 categories. These results indicate that HTTLF has diverse chemical spaces and polypharmacology with regards to the treatment of RA. In addition, HTTLF demonstrated therapeutic potential against diverse diseases other than RA, including osteoarthritis, atherosclerosis and brain cancer. This study provides a novel platform for understanding how HTTLF treats RA; this is beneficial for explaining the diverse functions of HTTLF with regards to RA, and may help develop novel compounds with desirable therapeutic targets to treat RA.

View Figures

View References

1	Qin ZJ: The research progress of rheumatoid arthritis in diagnosis and treatment of Chinese and western medicines. Acta Med Sin. 24:224–227. 2011.(In Chinese).
2	Fan FY and He XL: Research progress on traditional Chinese medicine for rheumatoid arthritis. Journal of Traditional Chinese Medicine University of Hunan. 26:60–61. 2006.(In Chinese).
3	Tong G, Zhang X, Tong W and Liu Y: Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: A meta-analysis. Hum Immunol. 74:586–592. 2013. View Article : Google Scholar : PubMed/NCBI
4	Xu J, Wang Q and Liu SY: Drug treatment of rheumatoid arthritis. Chin Community Doctors. 17:22–23. 2002.(In Chinese).
5	Niu LJ: Pharmacotherapy of rheumatoid arthritis. Pain Clin J. 2:106–109. 2006.(In Chinese).
6	Li QX: Research progress on immune mechanisms of traditional Chinese medicine for the treatment of rheumatoid arthritis. Research of Traditional Chinese Medicine. 18:53–55. 2002.(In Chinese).
7	Huang MC, Pai FT, Lin CC, Chang CM, Chang HH, Lee YC, Sun MF and Yen HR: Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: A nationwide population-based study. J Ethnopharmacol. 176:9–16. 2015. View Article : Google Scholar : PubMed/NCBI
8	Wang JM, Tao QW, Zhang YZ, Xu Y and Yan XP: Treating rheumatoid arthritis patients of Shen deficiency and cold invading syndrome by bushen quhan zhiwang decoction combined methotrexate: An evaluation of clinical efficacy and safety. Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:614–618. 2013.(In Chinese). PubMed/NCBI
9	Chen ZH: Clinical observation of Yishen Zhuanggu Tongbi Decoction in the Treatment of rheumatoid arthritis. Journal of Guangzhou University of Traditional Chinese Medicine. 22:19–22. 2005.(In Chinese).
10	Zhang YY, Chen JC, Qiu MS and Xu ZX: Clinical Observation of Huatan Tongluo Fang in the treatment of rheumatoid arthritis with phlegm-obstruction and blood-stasis Type. Traditional Chinese Medicine Journal. 11:49–52. 2012.(In Chinese).
11	Qiu MS, Chen JC, Zhang YY, Xu ZX, Jiang YF and Peng YF: Effect of Huatan Tongluo Fang on collagen-induced arthritis in rats. Journal of Beijing University of Traditional Chinese Medicine. 35:121–124. 2012.(In Chinese).
12	Zheng CS, Ye HZ, Xu XJ and Liu XX: Computational pharmacology study of tougu xiaotong granule in preventing and treating knee osteoarthritis. Chin J Integr Med. 15:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH, Huang SP and Liu XX: Computational approaches for exploring the potential synergy and polypharmacology of Duhuo Jisheng Decoction in the therapy of osteoarthritis. Mol Med Rep. 7:1812–1818. 2013.PubMed/NCBI
14	Shi SH, Cai YP, Cai XJ, Zheng XY, Cao DS, Ye FQ and Xiang Z: A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease. PLoS One. 9:e891232014. View Article : Google Scholar : PubMed/NCBI
15	Qiao X, Hou T, Zhang W, Guo S and Xu X: A 3D structure database of components from Chinese traditional medicinal herbs. J Chem Inf Comput Sci. 42:481–489. 2002. View Article : Google Scholar : PubMed/NCBI
16	Zhou JJ, Xie GR and Yang JX: Handbook of the Chemical Constituents in Chinese Herb Original Plants. Chemical Industry Press. Beijing: 1165–1211. 2004.(In Chinese).
17	Wang ZQ: Research progress of chemical composition and pharmacological effects of Rhizoma arisaematis. Drug Evaluation Research. 32:144–149. 2009.(In Chinese).
18	Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH, Xu HF and Liu XX: Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction and their application in osteoarthritis. Exp Ther Med. 6:125–132. 2013.PubMed/NCBI
19	Cheng SM, Wang HY, Li GY, Zhu Y, Zhao WB and Wang JH: Research progress of Bombyx batryticatus. Journal of Nongken Medicine. 34:443–448. 2012.(In Chinese).
20	Sheridan RP and Shpungin J: Calculating similarities between biological activities in the MDL Drug Data Report database. J Chem Inf Comput Sci. 44:727–740. 2004. View Article : Google Scholar : PubMed/NCBI
21	Hassan M, Bielawski JP, Hempel JC and Waldman M: Optimization and visualization of molecular diversity of combinatorial libraries. Mol Divers. 2:64–74. 1996. View Article : Google Scholar : PubMed/NCBI
22	Lipinski CA, Lombardo F, Dominy BW and Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 46:3–26. 2001. View Article : Google Scholar : PubMed/NCBI
23	Zhu F, Shi Z, Qin C, Tao L, Liu X, Xu F, Zhang L, Song Y, Liu X, Zhang J, et al: Therapeutic target database update 2012: A resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 40:D1128–D1136. 2012. View Article : Google Scholar : PubMed/NCBI
24	Hashimoto N, Iwasaki T, Kitano M, Ogata A and Hamano T: Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases. Mod Rheumatol. 3:129–134. 2003. View Article : Google Scholar
25	Rose PW, Prlić A, Bi C, Bluhm WF, Christie CH, Dutta S, Green RK, Goodsell DS, Westbrook JD, Woo J, et al: The RCSB Protein Data Bank: Views of structural biology for basic and applied research and education. Nucleic Acids Res. 43(D1): D345–D356. 2015. View Article : Google Scholar : PubMed/NCBI
26	Montes M, Braud E, Miteva MA, Goddard ML, Mondésert O, Kolb S, Brun MP, Ducommun B, Garbay C and Villoutreix BO: Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. J Chem Inf Model. 48:157–165. 2008. View Article : Google Scholar : PubMed/NCBI
27	Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T: Cytoscape 2.8: New features for data integration and network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
28	Dobson CM: Chemical space and biology. Nature. 432:824–828. 2004. View Article : Google Scholar : PubMed/NCBI
29	Tanaka Y: Current concepts in the management of rheumatoid arthritis. Korean J Intern Med. 31:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
30	Wang NN, Wang AW and Hao QX: New progress of study on traditional Chinese medicine for the treatment of rheumatoid arthritis. Modern Journal of Integrated Chinese Traditional and Western Medicine. 20:2334–2336. 2011.(In Chinese).
31	Zheng CE: The experience of research of integrated traditional Chinese and Western medicine for the treatment of rheumatoid arthritis. Integrated Traditional Chinese and Western Medicine. 4:255–256. 2012.(In Chinese).
32	Wu YJ, Lao ZY and Zhang ZL: Clinical observation on small doses Tripterygium wilfordii polyglycoside combined with methotrexate in treating rheumatoid arthritis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 21:895–896. 2001.(In Chinese). PubMed/NCBI
33	Li YS, Yang JH, Fan SY and Zhang YY: The experimental study of Tripterygium wilfordii polyglycoside combination therapy with glycyrrhizic acid for rheumatoid arthritis on efficacy enhancing and toxicity reducing. Chin J Tradit Med Sci Technol. 15:2932008.(In Chinese).
34	Kitano H: A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov. 6:202–210. 2007. View Article : Google Scholar : PubMed/NCBI
35	Chen M, Feng W, Cao H, Zou L, Chen C, Baatrup A, Nielsen AB, Li H, Kassem M, Zou X and Bünger C: A traditional Chinese medicine formula extracts stimulate proliferation and inhibit mineralization of human mesenchymal stem cells in vitro. J Ethnopharmacol. 125:75–82. 2009. View Article : Google Scholar : PubMed/NCBI
36	Li XD, Huang Q and Xu XJ: Target-Li gand space distribution of the compound sets from Xuefu Zhuyu Decoction, a traditional chinese medicinal recipe. Acta Physico-Chimica Sinica. 24:547–550. 2008.(In Chinese).
37	Ma JL, An LL and Xing X: Topology analysis on urban public traffic networks. Journal of Shanxi Teachers University. 23:51–55. 2009.(In Chinese).
38	Yang B, Qiu Y, Wang LP and Zhang XL: Studies on the anti-inflammatory molecular mechanism of chlorogenic acid extracted from Lonicera confusa DC in vitro. Chinese Pharmacological Bulletin. 25:542–545. 2009.(In Chinese).
39	Huang JQ, Sun WJ, Wang SW and Zhu MZ: Studies on the anti-inflammatory and antioxidant activity of quercetin in rats with gouty arthritis. China Journal of Experiment Traditional Medical Formulae. 18:169–173. 2012.(In Chinese).
40	Wang MY, Wei YF and Li XB: Chemical constituents of antirheumatism fraction from Urtica fissa. Chinese Traditional and Herbal Drugs. 37:1300–1303. 2006.(In Chinese).
41	Lv JZ and Deng JG: Research progress in pharmacological effects of amygdalin. Drugs & Clinic. 27:530–535. 2012.(In Chinese).
42	He ZK and Shen JW: The value of MMP-2, MMP-3, MMP-9 and TIMP-1 levels in the evaluation of knee joint osteoarthritis. Chongqing Medical Journal. 42:3872–3874. 2013.(In Chinese).
43	Wu ZB, Lu N, Wang YH, Shi ZG, Fan CM, Jia J, Liu L, Leng N and Zhu P: Association of serum MMP-2 and MMP-9 and progression of joint damage in early rheumatoid arthritis. Chinese Journal of Immunology. 22:260–262. 2006.(In Chinese).
44	Gao F, Chen LL, Yan SR, Guo SR, Zhao LH, Yang P, Zhang CW and Ji XB: Correlation between serum levels of MMP-1, MMP-9, TIMP-1, IL-6 and the severity of atherosclerotic coronary artery disease. Journal of Clinical Research. 30:2384–2386. 2013.(In Chinese).
45	Royall J and Lyon B: Sea-change or change challenge? Health information access in developing countries: The U.S. National Library of Medicine experience. Afr Health Sci. 11:457–463. 2011.PubMed/NCBI
46	Zhou C, Qian L, Ma H, Yu X, Zhang Y, Qu W, Zhang X and Xia W: Enhancement of amygdalin activated with β-D-glucosidase on HepG2 cells proliferation and apoptosis. Carbohydr Polym. 90:516–523. 2012. View Article : Google Scholar : PubMed/NCBI